Shenzhen Kangtai Biological Products Co., Ltd. (SHE:300601)
China
· Delayed Price · Currency is CNY 15.04
-0.54 (-3.47%)
Feb 28, 2025, 2:45 PM CST
SHE:300601 Revenue
Shenzhen Kangtai Biological Products had revenue of 816.14M CNY in the quarter ending September 30, 2024, with 11.21% growth. This brings the company's revenue in the last twelve months to 3.03B, down -0.84% year-over-year. In the year 2023, Shenzhen Kangtai Biological Products had annual revenue of 3.48B with 10.14% growth.
Revenue (ttm)
3.03B
Revenue Growth
-0.84%
P/S Ratio
5.57
Revenue / Employee
1.59M
Employees
1,902
Market Cap
16.78B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 3.48B | 320.04M | 10.14% |
| Jan 1, 2023 | 3.16B | -494.69M | -13.55% |
| Jan 1, 2022 | 3.65B | 1.39B | 61.51% |
| Dec 31, 2020 | 2.26B | 317.85M | 16.36% |
| Dec 31, 2019 | 1.94B | -73.57M | -3.65% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| Jiangsu Hengrui Medicine | 26.00B |
| WuXi AppTec | 38.50B |
| Aier Eye Hospital Group | 20.62B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Shanghai United Imaging Healthcare | 10.93B |
| Yunnan Baiyao Group Co.,Ltd | 39.34B |
| Beijing Wantai Biological Pharmacy Enterprise | 2.49B |